Back to Search Start Over

Early Identification and Management of Congenital Cytomegalovirus.

Authors :
Jenks CM
Mithal LB
Hoff SR
Source :
Otolaryngologic clinics of North America [Otolaryngol Clin North Am] 2021 Dec; Vol. 54 (6), pp. 1117-1127. Date of Electronic Publication: 2021 Sep 15.
Publication Year :
2021

Abstract

Congenital cytomegalovirus (cCMV) is the most common nongenetic cause of sensorineural hearing loss. Despite its prevalence, universal screening for cCMV is not currently performed. Hearing loss caused by cCMV is most often severe to profound, often bilateral, and may be fluctuating or progressive. Infants with hearing loss at birth and confirmed cCMV might benefit from antiviral therapy. Roughly half of hearing loss cases owing to cCMV are delayed in onset, and consequently, these children pass newborn hearing screening. Children with cCMV require close audiologic monitoring, require appropriate management with hearing aids, and should be monitored for cochlear implant candidacy.<br />Competing Interests: Disclosure Dr L.B. Mithal and Dr S.R. Hoff are site investigators in the ValEAR Trial, NIHU01 DC014706 (PI: Park).<br /> (Copyright © 2021 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1557-8259
Volume :
54
Issue :
6
Database :
MEDLINE
Journal :
Otolaryngologic clinics of North America
Publication Type :
Academic Journal
Accession number :
34535282
Full Text :
https://doi.org/10.1016/j.otc.2021.06.006